Risk factors for dementia (Q28262783)

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

0 references

Yen-Ching Chen

3

1 reference

ORCID Public Data File 2021

author name string

Jen-Hau Chen

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

Kun-Pei Lin

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

language of work or name

English

0 references

publication date

October 2009

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

Journal of the Formosan Medical Association

27 March 2017

published in

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

volume

108

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

issue

10

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

27 March 2017

page(s)

754-64

0 references

754-764

1 reference

https://doi.org/10.1016%2FS0929-6646%2809%2960402-2

Changing the trajectory of cognitive decline?

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Defining molecular targets to prevent Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Inflammatory processes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Genetically engineered mouse models of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

In-vivo measurement of activated microglia in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Beta-amyloid protein structure determines the nature of cytokine release from rat microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

How heritable is Alzheimer's disease late in life? Findings from Swedish twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Genetic susceptibility factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Molecular genetics of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Polymorphisms in inflammatory genes and the risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A genome-wide association study for late-onset Alzheimer's disease using DNA pooling

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Dementia and Alzheimer disease incidence: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Incidence of dementia in a rural community in Spain: the Girona cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Prevalence of dementia in China

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A community-based study of parental age at the birth of patients with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Parental age as a risk factor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Paternal age is a risk factor for Alzheimer disease in the absence of a major gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Incidence of dementia: does gender make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Incidence and etiology of dementia in a large elderly Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A prospective study of physical activity and cognitive decline in elderly women: women who walk

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Mental, physical and social components in leisure activities equally contribute to decrease dementia risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Physical activity and risk of cognitive impairment and dementia in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Walking and dementia in physically capable elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Physical activity and dementia: The need for prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Smoking, dementia and cognitive decline in the elderly, a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The influence of smoking on the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A 2-year follow-up study of cigarette smoking and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Benzodiazepine use and risk of dementia: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Estrogen replacement therapy and cognitive function in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Estrogen replacement therapy and cognitive decline in older community women.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

NSAIDs in the prevention of dementia: a Cache-22?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Postsecondary education and dementia risk in older Jesuit priests.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Education, cognitive test scores, and black-white differences in dementia risk

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Educational attainment and cognitive decline in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Alcohol and cardiovascular health: the razor-sharp double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Alcohol, dementia and cognitive decline in the elderly: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Prospective study of alcohol consumption and risk of dementia in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Alcohol consumption and transition of mild cognitive impairment to dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Alcohol intake and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Adiposity and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Midlife and late-life obesity and the risk of dementia: cardiovascular health study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Change in body mass index and risk of incident Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Hypertension and the risk of dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Links between Alzheimer's disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Understanding cognitive impairment and dementia: stroke studies

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Association between dementia and infectious disease: evidence from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

History of depression as a risk factor for dementia: an updated review.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960402-2

7 January 2021